When should a transthoracic echocardiogram be performed?

When Should a Transthoracic Echocardiogram Be Performed?

Transthoracic echocardiography should be performed in patients with suspected or known cardiac disease presenting with acute symptoms (chest pain, shortness of breath, syncope, hemodynamic instability) or when clinical findings suggest structural heart disease, but should NOT be routinely ordered in asymptomatic patients or used to delay urgent interventions. 1

Emergency and Acute Settings

Immediate TTE Indications (Perform Urgently)

Acute Coronary Syndrome:

• Perform TTE when history, ECG, and clinical risk scores fail to diagnose ACS before biomarker results are available
• Sensitivity improves from 71% with 2D wall motion analysis alone to 90% when adding regional strain analysis
• Use contrast for LV opacification when two or more myocardial segments cannot be adequately visualized 1

Acute Heart Failure:

• TTE is mandated in all patients with suspected heart failure to confirm diagnosis, quantify chamber volumes, assess systolic and diastolic function, and identify etiology
• Also required in known heart failure patients presenting with acute exacerbation to identify precipitating factors 1

Hemodynamic Compromise:

• Syncope with hemodynamic instability
• Unexplained hypotension
• Suspected cardiac tamponade
• Suspected acute valvular dysfunction 1

Acute Aortic Syndromes:

• TTE can serve as first-line imaging in the emergency room, but if negative, further imaging (TEE, CT) is mandatory
• Requires expert interpretation to minimize false positives/negatives 1

Chest Trauma:

• High sensitivity for detecting complications including intracardiac shunts, pericardial effusion/tamponade, valve lesions (especially tricuspid), and ventricular dilatation 1

Syncope and Palpitations

TTE is first-line imaging for:

• Highly symptomatic patients with high-grade AV block
• Ventricular or supraventricular arrhythmias
• Complicated new-onset atrial fibrillation
• A normal TTE is valuable as it helps direct diagnosis and management away from structural causes 1

Elevated Cardiac Biomarkers

Critical Decision Point: When troponin is elevated, TTE helps differentiate ACS from other causes including:

• Aortic valve disease
• Cardiomyopathies (hypertrophic, restrictive, Tako-tsubo)
• Endocarditis and myocarditis
• Heart failure 1

Practical threshold: A troponin level <0.25 ng/mL has a 94.3% negative predictive value for TTE findings that would change management 2

Non-Urgent Inpatient and Outpatient Settings

Shortness of Breath

Valvular Heart Disease:

• TTE is the primary imaging modality when VHD is suspected based on history or examination for diagnosis, severity assessment, and hemodynamic consequences 1

Cardiomyopathy:

• TTE is fundamental for diagnosis and classification of hypertrophic, dilated, arrhythmogenic, restrictive, and unclassified cardiomyopathies
• Essential for differentiating athlete's heart from pathologic conditions 1

Predictive Factors for Abnormal TTE

Order TTE when patients have:

• Age >50 years
• Serum troponin ≥0.1 ng/mL
• Abnormal ECG
• Clinical suspicion of heart failure or acute MI 2

When NOT to Perform TTE

Low-Yield Scenarios (Avoid Routine Use)

Emergency Non-Cardiac Surgery:

• TTE does not change course or outcomes of urgent interventions (ruptured AAA, major trauma, perforated viscus), even in patients with known cardiovascular disease 1

Post-Stroke Patients:

• Only 3.3% of TTEs changed management in acute ischemic stroke patients
• Do NOT delay hospital discharge solely to obtain TTE
• Cost per change in management: $16,832 3

Uncomplicated Penetrating Cardiac Injury:

• Routine postoperative TTE after single-operation repair without CPB, CABG, or staged procedures shows low clinical utility
• Reserve for patients with new cardiac symptoms, higher-risk injury patterns, or complex operative repair 4

ICU Patients Without Specific Indications:

• While routine TTE in ICU patients can detect abnormalities in 76.6% of cases, only specific clinical scenarios warrant the test
• Most common critical findings: sPAP >50 mmHg (19.6%), TAPSE ≤13mm (9.4%), grade III diastolic dysfunction (8.4%) 5
• However, 92.4% of TTEs in trauma/surgical ICU patients did not result in management changes 2

Preoperative Non-Cardiac Surgery

Perform TTE only when:

• Patient has cardiac symptoms
• Clinical risk stratification suggests increased perioperative cardiac risk
• Systolic dysfunction, moderate-to-severe LV hypertrophy, significant mitral regurgitation, or increased aortic valve gradient independently predict major cardiac complications 6

Do NOT perform in:

• Asymptomatic, low-risk patients undergoing non-cardiac surgery 7

Common Pitfalls to Avoid

1. Ordering TTE reflexively for elevated troponin <0.25 ng/mL without other clinical indicators 2
2. Delaying discharge to obtain TTE when it won't change immediate management 3
3. Using TTE as a screening tool in asymptomatic patients before non-cardiac surgery 7
4. Relying solely on TTE for acute aortic syndromes—negative TTE requires further imaging 1
5. Ordering routine postoperative TTE after uncomplicated cardiac injury repair 4